Literature DB >> 25872879

A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties.

Rajshekhar Chakraborty1, Bipin N Savani2, Mark Litzow3, Mohamad Mohty4, Shahrukh Hashmi3.   

Abstract

The widespread use of complementary and alternative medicine (CAM) in cancer survivors is well known despite a paucity of scientific evidence to support its use. The number of survivors of hematopoietic stem cell transplant (HCT) is growing rapidly and HCT clinicians are aware that many of their patients use CAM therapies consistently. However, due to a paucity of data regarding the benefits and harms of CAM therapies in these survivors, clinicians are reluctant to provide specific recommendations for or against particular CAM therapies. A systematic literature review was conducted with a search using PubMed, the Cochrane Database of Systematic Reviews, and Ovid online for each CAM therapy as defined by the National Center of Complementary and Alternative Medicine. The search generated 462 references, of which 26 articles were deemed to be relevant for the review. Due to extensive heterogeneity in data and limited randomized trials, a meta-analysis could not be performed but a comprehensive systematic review was conducted with specified outcomes for each CAM therapy. In randomized controlled trials, certain mind and body interventions such as relaxation were observed to be effective in alleviating psychological symptoms in patients undergoing HCT, whereas the majority of the other CAM treatments were found to have mixed results. CAM use is an understudied area in HCT survivorship and clinicians should convey the benefits and uncertainties concerning the role of CAM therapies to their patients.
© 2015 American Cancer Society.

Entities:  

Keywords:  complementary and alternative medicine (CAM); hematopoietic stem cell transplant (HCT); quality of life; survivors

Mesh:

Substances:

Year:  2015        PMID: 25872879     DOI: 10.1002/cncr.29382

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

Review 1.  Palliative care during and following allogeneic hematopoietic stem cell transplantation.

Authors:  Sandra A Mitchell
Journal:  Curr Opin Support Palliat Care       Date:  2018-03       Impact factor: 2.302

2.  Most National Cancer Institute-Designated Cancer Center Websites Do Not Provide Survivors with Information About Cancer Rehabilitation Services.

Authors:  Julie K Silver; Vishwa S Raj; Jack B Fu; Eric M Wisotzky; Sean Robinson Smith; Sasha E Knowlton; Alexander J Silver
Journal:  J Cancer Educ       Date:  2018-10       Impact factor: 2.037

3.  The effect of Tai Chi practice on immunological function in cancer survivors: A protocol for systematic review.

Authors:  Xuejiao Wang; Lei Xu; Ning Dai; Xingzhe Yang; Qingyun He; Libo Tan; Ruochong Wang; Feng Li
Journal:  Medicine (Baltimore)       Date:  2020-09-04       Impact factor: 1.889

Review 4.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.

Authors:  Margaret Bevans; Areej El-Jawahri; D Kathryn Tierney; Lori Wiener; William A Wood; Flora Hoodin; Erin E Kent; Paul B Jacobsen; Stephanie J Lee; Matthew M Hsieh; Ellen M Denzen; Karen L Syrjala
Journal:  Biol Blood Marrow Transplant       Date:  2016-09-19       Impact factor: 5.742

5.  Epidemiology of complementary and alternative medicine therapy use in allogeneic hematopoietic stem cell transplant survivorship patients in Australia.

Authors:  Julian Lindsay; Masrura Kabir; Nicole Gilroy; Gemma Dyer; Lisa Brice; John Moore; Matthew Greenwood; Mark Hertzberg; David Gottlieb; Stephen R Larsen; Megan Hogg; Louisa Brown; Gillian Huang; Jeff Tan; Christopher Ward; Ian Kerridge
Journal:  Cancer Med       Date:  2016-10-27       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.